SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing presentation: reset
POPPK MODELING OF Q2M IM RPV LA FOR MANAGING DOSING INTERRUPTIONS IN HIV-1 PATIENTS
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
1 of
1
|
POPPK MODELING OF Q2M IM RPV LA FOR MANAGING DOSING INTERRUPTIONS IN HIV-1 PATIENTS (ABSTRACT
403)
Herta Crauwels
Janssen Pharmaceutica, Beerse, Belgium
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
1 of
1
|